Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by RealScientiston Jan 28, 2016 10:53pm
231 Views
Post# 24504360

RE:RE:RE:RE:Got A Question For Everyone

RE:RE:RE:RE:Got A Question For EveryoneTo follow up on this, take a look at the trading between March and June 2015. There were a number of times the stock was 10 cents over the exercise price (50 cents) and was above for 9 days only to drop on the 10th day to 49 cents. And usually the next trading day, the stock price would be back over 50 cents. It will be interesting to see how things turn out in the next month or so. 60 cents looks possible, but look at the trend during this time over a 10 day period and see when the selling starts to keep it below 60. It's only a matter of time before this takes off and I'm curious to see if it will be able to be held back. With a lot of eyes here and Nick Hodge on board, I think it's going to take quite a bit to keep the lid from blowing off. 

 
dart321 wrote: sorry for this confusion, let me explain a bit better. The financing this was part of, has nothing to do with present management it was completed in 2013 before Arun joined the company. The warrants where for three years exercisable @ 30 cents the first year @ 40 cents the second year and @ 50 cents the third year. There is a exercise clause within the agreement whereby if the shares trade at 10 cents above the exercise price for a period of&nbsp;10 consecutive days the holders are obligated to exercise the warrant. So what we are really looking at is 60 cents. I believe I was told last year in the fall that half of these warrants have all<br /> ready been exercised.&nbsp;<br /> <br /> There is a second possible reason for the instint walls put up.&nbsp;The stock was moving up to fast.<br />
Bullboard Posts